The United States supports raising vaccine patents and the World Health Organization welcomes


Posted in:

                US President Joe Biden on Wednesday expressed his support for lifting the patents for Covid-19 vaccines, before his administration confirmed its participation in negotiations on the conditions for this at the World Trade Organization.  The Director General of the World Health Organization praised the "historic decision."  India and South Africa, in particular, are calling for the temporary lifting of patents on vaccines in order to be able to speed up production, but some countries, including France, are against it.

                                    <p>in shade <a target="_blank" href="آسيا/20210505-مجموعة-السبع-تناقش-ملف-تشارك-لقاحات-فيروس-كورونا-مع-تزايد-ضغوط-الدول-الفقيرة" rel="noopener"><strong>Pressure </strong></a>An increasing number of Democratic lawmakers and more than 100 other countries, the US administration announced Wednesday its support for a global patent filing <a target="_blank" href="أمريكا/20210501-موديرنا-يصبح-خامس-لقاح-ضد-فيروس-كورونا-ينال-ترخيص-منظمة-الصحة-العالمية" rel="noopener"><strong>Vaccines </strong></a>Anti <a target="_blank" href="برامج/ريبورتاج/20210504-قارورة-الأكسجين-هذه-لي-الهند-تدخل-منعطفا-خطيرا-في-مواجهة-كورونا" rel="noopener"><strong>Coronavirus</strong></a>, Explaining that it is participating in negotiations on terms for that in the World Trade Organization

And across the US President Of the bygones His support for a temporary waiver of rights, in a radical change from the previous US position, after a speech at the White House, was quickly followed by an official statement from chief trade negotiator Catherine Tay.

US Trade Representative Catherine Tye said in the statement that the intellectual property rights of companies are important, but that Washington “supports the waiver of that protection for Covid-19 vaccines.” “This is a global health crisis, and the exceptional circumstances of the Covid-19 pandemic call for exceptional measures to be taken,” she added.

For his part, the Director-General of the World Health Organization, Tedros Adhanom Ghebreyesus, praised on Wednesday the “historic decision” of the United States for its support for a temporary lifting of the patents for anti-Corona vaccines, which will be terminated according to experts in the shortage of supplies.

“I salute the United States for this historic decision in favor of fairness in vaccines, giving priority to the well-being of everyone everywhere at this critical time. Let us now all move forward with speed and solidarity to build on the ingenuity and commitment of the scientists who produced the Covid-19 vaccines that save Spirits. ”

Ghebreyesus has been urging months ago to take this action, and he considers that the WTO texts allow this temporary lifting in the event of a dangerous event.

“If we don’t do it now, then when?” He has repeatedly stated at a time when the world is facing its worst pandemic in a century when vaccines are already in place.

The American official added that her country is participating “actively” in the ongoing negotiations at the World Trade Organization regarding the lifting of these patents.

World Trade Organization Director-General Ngozi Okonjo-Iweala has made access to vaccines a priority for her institution.

‘Complicated problem’

India and South Africa, in particular, are calling for the temporary lifting of patents on vaccines in order to be able to speed up production, but some countries, including France, are against it.

Instead, Paris is asking for donations in favor of poor countries.

Powerful pharmaceutical companies generally oppose suspending their patents, arguing that doing so would prevent costly research.

Kathryn Tay acknowledged that negotiations at the World Trade Organization “will take time given the consensual nature of the institution and the complexity of the issues at hand.”

She emphasized that “the goal (…) is to provide the largest possible number of safe and effective vaccines to the largest possible number of people as soon as possible.”

And she stressed that “the department will continue to intensify its efforts, in cooperation with the private sector and all potential partners, to expand vaccine manufacturing and distribution.”

Agence France-Presse contacted US pharmaceutical companies Johnson & Johnson, Pfizer and Moderna on Wednesday afternoon, but did not receive a response.

In a statement Wednesday, the International Federation of Manufacturers and Pharmaceutical Societies said that the US decision was “disappointing.”

“We fully agree with the goal of rapidly and justly sharing COVID-19 vaccines around the world. But as we have said time and time again, suspending (for patents) is the easy but wrong solution to a complex problem.”

On Wall Street, vaccine manufacturers’ shares fell on Wednesday at the end of the session, following the US announcement.

Shares of a company fell Moderna Included in the Nasdaq index increased by 6.19 percent to $ 162.84. The share of Novavax, whose vaccine is still being studied, fell by about 5 percent.

It remained a company share Pfizer The share of its German partner Bayontak fell by 3.45 percent, and Johnson & Johnson lost 0.42 percent of its value.

France 24 / AFP / Reuters



Please enter your comment!
Please enter your name here